The Feasibility and Long-Term Outcomes of the Crossboss/Stingray for Treating Coronary Chronic Total Occlusions Lesions with Distal Diffuse Disease Landing Zone

CONCLUSIONS: In CTO lesions with distal diffuse disease landing zone, the technical success rates of CrossBoss/Stingray and the long-term clinical outcomes were not significantly different between the moderate stenosis group (50%-70%) and the severe stenosis group (>70%). However, the relatively high rate of long-term clinical outcomes, especially any revascularization, warrants further investigations on this indication in future studies.PMID:35345280 | DOI:10.31083/j.rcm2303113

Source: Reviews in Cardiovascular Medicine - March 29, 2022 Category: Cardiology Authors: Rutao Wang Genrui Chen Fangjun Mou Yi Liu Zhiyong Yin Bo Wang Haokao Gao Chao Gao Ling Tao Chengxiang Li Source Type: research